FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns a drug preparation showing stimulating action on lymphocytopoiesis with an immunophenotype similar to that of lymphokine-activated killer cells. Substance of the invention consists in the fact that the offered drug preparation contains sodium nucleinate 2 to 50 mg/ml, sodium chloride 3 to 10 mg/ml and apyrogenic water with pH 6.0 to 7.5.
EFFECT: drug preparation activates killer cells effectively lysing tumour cells.
3 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING ACTIVATED LEUKOCYTES FOR ADJUVANT ADOPTIVE IMMUNOTHERAPY OF MALIGNANT GROWTHS | 2009 |
|
RU2414915C2 |
ALLOPHERONES AS IMMUNOMODULATING PEPTIDES | 1999 |
|
RU2172322C1 |
METHOD OF OBTAINING DEPOSITED LYMPHOKINE-ACTIVATED KILLER CELLS | 2009 |
|
RU2400238C1 |
METHOD OF PRODUCING LYMPHOCYTES CYTO-TOXIC TO CANCER CELLS, AND METHOD OF PRODUCING GLYCO-BOUND SUBSTANCE | 0 |
|
SU1412596A3 |
METHOD FOR CANCER ADOPTIVE IMMUNOTHERAPY | 2016 |
|
RU2613884C1 |
DRUG PREPARATION SHOWING ANTIVIRAL PROPERTIES | 2010 |
|
RU2435606C1 |
METHOD FOR ACTIVATION OF CYTOTOXIC LYMPHOCYTES | 2019 |
|
RU2751837C2 |
TLP-BASE IMMUNOGENIC COMPOSITION | 1997 |
|
RU2192274C2 |
BIOMEDICAL CELL PRODUCT WITH ANTI-HER2 SPECIFIC ANTI-TUMOUR ACTIVITY | 2019 |
|
RU2728361C1 |
METHOD OF TREATING PATIENTS SUFFERING LUNG CANCER | 2012 |
|
RU2500435C1 |
Authors
Dates
2012-02-27—Published
2010-10-18—Filed